In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users

Addiction
H Valerie Curran, L Monaghan

Abstract

Ketamine, a non-competitive NMDA receptor antagonist, produces acute impairments of working, episodic and semantic memory along with psychotogenic and dissociative effects when a single dose is given to healthy volunteers. In recreational users, Curran & Morgan (2000) showed that ketamine produced the same acute effects but that 3 days after ingestion, ketamine users showed persisting memory impairment and elevated psychotogenic symptoms compared with controls. To explore whether such persisting effects reflect chronic effects of ketamine use, the present study compared frequent with infrequent users of ketamine on the night of drug use and again 3 days later. Eighteen frequent and 19 infrequent ketamine users were assessed on each test day on a range of cognitive tasks tapping memory and attentional function and on subjective scales (schizotypal symptomatology, dissociation, mood). Groups were broadly matched for polydrug use apart from ketamine which frequent users took significantly more often and in larger quantities than infrequent users. Acute effects on day 0 replicated previous findings. On day 3 frequent users showed significant impairments on tasks tapping episodic and semantic memory but there was no evidence of pers...Continue Reading

Citations

Sep 24, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Philip R CorlettPaul C Fletcher
Feb 7, 2012·CNS Drugs·Sanjay J MathewJames W Murrough
Jul 29, 2005·Substance Use & Misuse·Stephen E Lankenau, Michael C Clatts
Jul 14, 2010·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Osama ElsewaisyJohn Monagle
May 5, 2011·Expert Review of Neurotherapeutics·Robert J SchwartzmanJohn R Grothusen
Sep 21, 2016·Dermatitis : Contact, Atopic, Occupational, Drug·Abigail E Cline, Jake E Turrentine
Jul 28, 2004·Molecular Psychiatry·D C Javitt
Jul 29, 2005·Substance Use & Misuse·Louisa DegenhardtPaul Dillon
Jan 9, 2009·Pain·Rae Frances Bell
Sep 11, 2010·Expert Opinion on Pharmacotherapy·Ingeborg NoppersAlbert Dahan
Feb 26, 2013·British Journal of Clinical Pharmacology·Marieke NiestersAlbert Dahan
Mar 22, 2014·Journal of Pharmacy Practice·Gyula Bokor, Peter D Anderson
Mar 9, 2012·European Addiction Research·Tina Van HavereEric Broekaert
Apr 1, 2015·The American Journal on Addictions·James X LiuStephen Ross
Sep 16, 2014·Synapse·Rebecca M RuddyAmy J Ramsey
Jul 20, 2016·Journal of Psychoactive Drugs·Evelyn Hearne, Marie Claire Van Hout
Feb 20, 2017·Forensic Sciences Research·Ricardo Jorge Dinis-Oliveira
Mar 23, 2019·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Debryna D LumanauwDavid A Tanen
Apr 21, 2020·Anesthesiology Research and Practice·Abby PribishArun Kalava
Sep 29, 2006·Psychopharmacology·Celia J A Morgan, H Valerie Curran
Jul 29, 2005·Substance Use & Misuse·Jane Carlisle Maxwell
Oct 25, 2008·Psychopharmacology·Mark BlagroveBrigitte Brandner
Nov 28, 2013·Pharmaceuticals·Seven E TomekM Foster Olive
Jun 21, 2011·The Journal of Urology·S K MakC Y Man
May 31, 2017·Biomedical Chromatography : BMC·Eylem Funda Göktaş, Filiz Arıöz
Mar 9, 2018·CNS Drugs·Panos ZanosTodd D Gould
Oct 23, 2008·Addiction Research & Theory·Stephen E LankenauDodi Hathazi
Jul 23, 2011·Addiction·Celia J A MorganUNKNOWN Independent Scientific Committee on Drugs
Aug 7, 2013·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Amy Lee BredlauRobert H Dworkin
Feb 22, 2011·Pharmacogenomics·Markus R Meyer, Hans H Maurer
Feb 26, 2015·Journal of Psychoactive Drugs·Marie Claire Van Hout, Evelyn Hearne
Jun 23, 2016·Depression and Anxiety·Sean Sassano-HigginsMark Gold
Mar 4, 2019·CNS Drugs·Denise Kreutzwiser, Qutaiba A Tawfic
Feb 23, 2019·Critical Reviews in Toxicology·Andrea G BarthwellKenneth Egli
Feb 28, 2016·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Minseung KimJang-Han Lee
Sep 18, 2002·Drug and Alcohol Dependence·Michael A TaffeLisa H Gold

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.